Published in J Infect Dis on June 07, 2002
Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J Clin Microbiol (2004) 2.41
Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines. Infect Immun (2008) 1.66
Prospects for vaccine prevention of meningococcal infection. Clin Microbiol Rev (2006) 1.53
Meningococcal disease: changes in epidemiology and prevention. Clin Epidemiol (2012) 1.48
sodC-based real-time PCR for detection of Neisseria meningitidis. PLoS One (2011) 1.45
PCR-based assay for detection of Neisseria meningitidis capsular serogroups 29E, X, and Z. J Clin Microbiol (2004) 1.34
Biofilm formation by Neisseria meningitidis. Infect Immun (2004) 1.05
Carriage of meningococci by university students, United Kingdom. Emerg Infect Dis (2011) 0.86
Invasive meningococcal disease epidemiology and control measures: a framework for evaluation. BMC Public Health (2007) 0.81
Meningococcal factor H binding protein fHbpd184 polymorphism influences clinical course of meningococcal meningitis. PLoS One (2012) 0.78
Meningococcal carriage during a clonal meningococcal B outbreak in France. Eur J Clin Microbiol Infect Dis (2013) 0.78
Evolution of meningococcal carriage in serogroups X and Y before introduction of MenAfriVac in the health district of Kaya, Burkina Faso. BMC Infect Dis (2014) 0.75
A Survey of Serum Bactericidal Antibodies against Neisseria meningitidis Serogroups A, C, W and Y in Adolescents and Adults in the Republic of Korea. Infect Chemother (2016) 0.75
Case-Control Study of Risk Factors for Meningococcal Disease in Chile. Emerg Infect Dis (2017) 0.75
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med (2003) 15.48
Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med (2005) 12.75
Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis (2010) 8.37
Burden of Clostridium difficile infection in the United States. N Engl J Med (2015) 8.17
Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med (2006) 7.68
Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis (2007) 6.45
Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA (2008) 6.13
Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet (2006) 5.56
FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. Clin Infect Dis (2004) 5.53
The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis (2007) 5.36
Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA (2005) 5.29
Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis (2002) 5.23
Identification of anthrax toxin genes in a Bacillus cereus associated with an illness resembling inhalation anthrax. Proc Natl Acad Sci U S A (2004) 4.73
Characterization of encapsulated and noncapsulated Haemophilus influenzae and determination of phylogenetic relationships by multilocus sequence typing. J Clin Microbiol (2003) 4.47
Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med (2009) 4.38
Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. Clin Infect Dis (2002) 4.08
Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat Med (2003) 3.54
Fatal inhalational anthrax in a 94-year-old Connecticut woman. JAMA (2002) 3.26
Characterization of Bacillus cereus isolates associated with fatal pneumonias: strains are closely related to Bacillus anthracis and harbor B. anthracis virulence genes. J Clin Microbiol (2006) 3.15
Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. JAMA (2004) 3.05
The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis (2003) 3.04
Molecular subtyping of Bacillus anthracis and the 2001 bioterrorism-associated anthrax outbreak, United States. Emerg Infect Dis (2002) 2.99
Bacterial meningitis in the United States, 1998-2007. N Engl J Med (2011) 2.99
Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA (2006) 2.93
Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex. J Infect Dis (2002) 2.88
Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med (2013) 2.78
Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg Infect Dis (2002) 2.76
Investigations of 2 cases of diphtheria-like illness due to toxigenic Corynebacterium ulcerans. Clin Infect Dis (2008) 2.73
Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin Infect Dis (2009) 2.56
Sequencing of 16S rRNA gene: a rapid tool for identification of Bacillus anthracis. Emerg Infect Dis (2002) 2.54
Population-based study of invasive disease due to beta-hemolytic streptococci of groups other than A and B. Clin Infect Dis (2009) 2.53
Invasive infections with Haemophilus influenzae serotype a containing an IS1016-bexA partial deletion: possible association with virulence. Clin Infect Dis (2005) 2.43
Leptospirosis in "Eco-Challenge" athletes, Malaysian Borneo, 2000. Emerg Infect Dis (2003) 2.35
Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax. J Infect Dis (2004) 2.29
Evaluation and validation of a real-time polymerase chain reaction assay for rapid identification of Bacillus anthracis. Emerg Infect Dis (2002) 2.23
Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis. J Clin Microbiol (2004) 2.20
Use of 16S rRNA gene sequencing for rapid identification and differentiation of Burkholderia pseudomallei and B. mallei. J Clin Microbiol (2003) 2.15
Pathology and pathogenesis of bioterrorism-related inhalational anthrax. Am J Pathol (2003) 2.11
Surface sampling methods for Bacillus anthracis spore contamination. Emerg Infect Dis (2002) 2.11
Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins. Infect Immun (2005) 2.05
Cationic antimicrobial peptide resistance in Neisseria meningitidis. J Bacteriol (2005) 1.99
Use of 16S rRNA gene sequencing for rapid confirmatory identification of Brucella isolates. J Clin Microbiol (2004) 1.97
The scientific basis for law as a public health tool. Am J Public Health (2008) 1.91
Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study. J Infect Dis (2011) 1.91
Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. Clin Infect Dis (2012) 1.91
Invasive Salmonella infections in the United States, FoodNet, 1996-1999: incidence, serotype distribution, and outcome. Clin Infect Dis (2004) 1.85
Antimicrobial susceptibility testing of Bacillus anthracis: comparison of results obtained by using the National Committee for Clinical Laboratory Standards broth microdilution reference and Etest agar gradient diffusion methods. J Clin Microbiol (2002) 1.83
Serogroup W-135 meningococcal disease during the Hajj, 2000. Emerg Infect Dis (2003) 1.81
FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance. Antimicrob Agents Chemother (2010) 1.79
Mutator clones of Neisseria meningitidis in epidemic serogroup A disease. Proc Natl Acad Sci U S A (2002) 1.77
Comparative genomics of Neisseria meningitidis: core genome, islands of horizontal transfer and pathogen-specific genes. Microbiology (2006) 1.75
Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. J Clin Microbiol (2012) 1.68
Genetic basis for nongroupable Neisseria meningitidis. J Infect Dis (2003) 1.62
Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States. Clin Infect Dis (2008) 1.60
Neisseria meningitidis lipooligosaccharide structure-dependent activation of the macrophage CD14/Toll-like receptor 4 pathway. Infect Immun (2004) 1.59
Comparison of detection methods for heteroresistant vancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method. J Clin Microbiol (2010) 1.57
Hospitalizations and deaths due to Salmonella infections, FoodNet, 1996-1999. Clin Infect Dis (2004) 1.55
A two-component direct fluorescent-antibody assay for rapid identification of Bacillus anthracis. Emerg Infect Dis (2002) 1.54
Characterization of genetic and phenotypic diversity of invasive nontypeable Haemophilus influenzae. Infect Immun (2005) 1.53
Bacillus anthracis aerosolization associated with a contaminated mail sorting machine. Emerg Infect Dis (2002) 1.52
Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Pediatrics (2008) 1.51
A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factor. Clin Infect Dis (2007) 1.51
Identification of Haemophilus influenzae serotypes by standard slide agglutination serotyping and PCR-based capsule typing. J Clin Microbiol (2003) 1.50
An overview of adverse events reported by participants in CDC's anthrax vaccine and antimicrobial availability program. Pharmacoepidemiol Drug Saf (2005) 1.50
Herd immunity and pneumococcal conjugate vaccine: a quantitative model. Vaccine (2007) 1.49
Meningococcal disease: changes in epidemiology and prevention. Clin Epidemiol (2012) 1.48
Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis (2003) 1.48
Racial disparities in invasive Streptococcus pneumoniae infections, 1998-2009. Clin Infect Dis (2014) 1.47
Assessing the risk of laboratory-acquired meningococcal disease. J Clin Microbiol (2005) 1.47
Description and nomenclature of Neisseria meningitidis capsule locus. Emerg Infect Dis (2013) 1.47
Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics (2002) 1.47
Public health in the time of bioterrorism. Emerg Infect Dis (2002) 1.46
sodC-based real-time PCR for detection of Neisseria meningitidis. PLoS One (2011) 1.45
Sequence diversity of Neisseria meningitidis 16S rRNA genes and use of 16S rRNA gene sequencing as a molecular subtyping tool. J Clin Microbiol (2002) 1.45
Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines. J Infect Dis (2011) 1.42
Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002. Clin Infect Dis (2006) 1.36
First case of bioterrorism-related inhalational anthrax in the United States, Palm Beach County, Florida, 2001. Emerg Infect Dis (2002) 1.34
Invasive listeriosis in the Foodborne Diseases Active Surveillance Network (FoodNet), 2004-2009: further targeted prevention needed for higher-risk groups. Clin Infect Dis (2012) 1.34
Identification of superantigen genes speM, ssa, and smeZ in invasive strains of beta-hemolytic group C and G streptococci recovered from humans. FEMS Microbiol Lett (2003) 1.34
Socioeconomic and racial/ethnic disparities in the incidence of bacteremic pneumonia among US adults. Am J Public Health (2010) 1.33
Capsule gene analysis of invasive Haemophilus influenzae: accuracy of serotyping and prevalence of IS1016 among nontypeable isolates. J Clin Microbiol (2007) 1.33
Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization. AIDS (2010) 1.32
Anthrax lethal toxin paralyzes neutrophil actin-based motility. J Infect Dis (2005) 1.32
Phosphoethanolamine substitution of lipid A and resistance of Neisseria gonorrhoeae to cationic antimicrobial peptides and complement-mediated killing by normal human serum. Infect Immun (2008) 1.32
NAP1 strain type predicts outcomes from Clostridium difficile infection. Clin Infect Dis (2014) 1.31
Preliminary evaluation of the API 20NE and RapID NF plus systems for rapid identification of Burkholderia pseudomallei and B. mallei. J Clin Microbiol (2005) 1.31
Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005. J Infect Dis (2010) 1.31